Evonik
Leading Beyond Chemistry
Company Presentation Q3 2021
Key messages Q3 2021
FCF outlook raised to ~€1 bn - Set for structural growth in FY 2022
Q3 with adj. EBITDA of €645 m continuing on strong Q2 level … despite ~€30 m negative temporary & one-time effects
Price increases gaining track: Q3 at +8% in growth divisions (Q2: +2%)
Cost inflation managed well and compensated by price increases already in Q3
Sustained positive trends into Q4 - FY adj. EBITDA outlook specified to ~€2.4 bn (top end of previous range)
Record strong FCF of €937 m in 1-92021 - FY FCF outlook raised to ~€1 bn
Growth drivers in place & cost inflation under control - Set for continued structural growth in FY 2022
2 | November / December 2021 | Evonik Q3 2021 Company Presentation
Table of contents
- Evonik at a glance
- Strategy
- Financials Q3 2021
- Appendix
3 | November / December 2021 | Evonik Q3 2021 Company Presentation
LEADING BEYOND CHEMISTRY
TO IMPROVE LIFE, TODAY AND TOMORROW
4 | November / December 2021 | Evonik Q3 2021 Company Presentation
Leading Beyond Chemistry - Our purpose
Evonik on the way to become a best-in-class specialty chemicals company
Video "We are Evonik"
Leading …
… Beyond …
… Chemistry
- Leading market positions in 80% of our business
- Leading key financial indicators
- Connecting skills and perspectives
- Develop solutions together with partners
- Sustainability key driver of growth
- Clear focus on specialty chemicals
- Target 100% specialty portfolio
5 | November / December 2021 | Evonik Q3 2021 Company Presentation
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 08 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 November 2021 08:02:05 UTC.